Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness and Safety of Mesenchymal Stem Cell Therapy in Long COVID Patients

NCT06492798 is registered in ClinicalTrials.gov with Changhai Hospital as lead sponsor.

NCT NCT06492798
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06492798 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness and Safety of Mesenchymal Stem Cell Therapy in Long COVID Patients
Lead sponsor
Changhai Hospital
Phase
Phase 1/2
Overall status
Recruiting
Start date
September 1, 2023
Completion date
August 31, 2026
Enrollment
76 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

long covid, post-acute covid-19 syndrome